DMBT1 Protein (AA 2008-2413) (His tag)
-
- Target See all DMBT1 Proteins
- DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 2008-2413
- Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This DMBT1 protein is labelled with His tag.
- Application
- Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
- Sequence
- Cys2008-Arg2413
- Characteristics
- Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1), Prokaryotic expression, Cys2008-Arg2413, N-terminal His Tag
- Purity
- > 95 %
- Top Product
- Discover our top product DMBT1 Protein
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Isoelectric Point:6.7
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-80 °C
- Storage Comment
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))
- Alternative Name
- Deleted In Malignant Brain Tumors 1 (DMBT1 Products)
- Synonyms
- GP340 Protein, muclin Protein, CRP Protein, CRP-[a] Protein, CRP-[b] Protein, Crpd Protein, DBMT1 Protein, gp300 Protein, p80 Protein, DMBT1 Protein, gp340 Protein, deleted in malignant brain tumors 1 Protein, deleted in malignant brain tumors 1 protein Protein, gp340 Protein, deleted in malignant brain tumors 1 S homeolog Protein, DMBT1 Protein, Dmbt1 Protein, LOC100064515 Protein, dmbt1 Protein, ST201phi2-1p340 Protein, dmbt1.S Protein
- Background
- GP340, SAG, Muclin, Glycoprotein 340, Hensin, Salivary agglutinin, Surfactant pulmonary-associated D-binding protein
- Molecular Weight
- 50kDa
- UniProt
- Q9UGM3
- Pathways
- Activation of Innate immune Response
-